VBI Vaccines
VBIV
#10656
Rank
S$2.38 M
Marketcap
S$0.08331
Share price
0.00%
Change (1 day)
-89.62%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$12.94. In 2022 the company made an earnings per share (EPS) of S-$16.84 a decrease over its 2021 EPS that were of S-$10.33.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$16.8462.96%
2021S-$10.3328.57%
2020S-$8.04-54.35%
2019S-$17.61-52.58%
2018S-$37.1310.23%
2017S-$33.6814.29%
2016S-$29.47-62.8%
2015S-$79.2390.68%
2014S-$41.55-7.95%
2013S-$45.14-57.97%
2012S-$107.41-78%
2011S-$488.313151.47%
2010S-$15.0223.87%
2009S-$12.12-18.48%
2008S-$14.8712.08%
2007S-$13.27-49.47%
2006S-$26.26
2005N/A-100%
2004S-$11.6811.94%
2003S-$10.43-81.89%
2002S-$57.59196.44%
2001S-$19.4384.33%
2000S-$10.54-65.37%
1999S-$30.44-29.45%
1998S-$43.1429.61%
1997S-$33.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.21-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.68-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.52-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA